Clinical Trial Update: De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial exploring de-escalation or switching therapy guided by circulating tumor DNA after two cycles of doublet chemotherapy plus a targeted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University Hospital, Rouen | Conditions: Metastatic Colon Cancer | Phase 3 | Status: NOT_YET_RECRUITING